Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evaluating Ebola therapies--the case for RCTs.

Literature DB >> 25470568

Evaluating Ebola therapies--the case for RCTs.

Edward Cox¹, Luciana Borio, Robert Temple.

Abstract

Entities: Species

Mesh：

Year: 2014 PMID： 25470568 DOI： 10.1056/NEJMp1414145

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

28 in total

1. The Confounding Question of Confounding Causes in Randomized Trials.

Authors: Jonathan Fuller
Journal: Br J Philos Sci Date: 2018-01-22 Impact factor: 3.978

2. Monitoring and Assessment of Medical Countermeasures as Part of a Public Health Emergency Response.

Authors: Gregory T Measer; Carmen T Maher; Jean Hu-Primmer
Journal: Am J Public Health Date: 2018-09 Impact factor: 9.308

3. A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection.

Authors: Richard T Davey; Lori Dodd; Michael A Proschan; James Neaton; Jacquie Neuhaus Nordwall; Joseph S Koopmeiners; John Beigel; John Tierney; H Clifford Lane; Anthony S Fauci; Moses B F Massaquoi; Foday Sahr; Denis Malvy
Journal: N Engl J Med Date: 2016-10-13 Impact factor: 91.245

4. Evaluating Anti-Infective Drugs in the Resistant Pathogen Setting: Can we Use External Controls?

Authors: Scott R Evans; John Powers
Journal: Stat Commun Infect Dis Date: 2017-03-14

5. Design of a Randomized Controlled Trial for Ebola Virus Disease Medical Countermeasures: PREVAIL II, the Ebola MCM Study.

Authors: Lori E Dodd; Michael A Proschan; Jacqueline Neuhaus; Joseph S Koopmeiners; James Neaton; John D Beigel; Kevin Barrett; Henry Clifford Lane; Richard T Davey
Journal: J Infect Dis Date: 2016-02-11 Impact factor: 5.226

10. The Past Need Not Be Prologue: Recommendations for Testing and Positioning the Most-Promising Medical Countermeasures for the Next Outbreak of Ebola Virus Infection.

Authors: Richard T Davey; Lori Dodd; Michael Proschan; Peter Jahrling; Lisa Hensley; Elizabeth Higgs; H Clifford Lane
Journal: J Infect Dis Date: 2018-11-22 Impact factor: 5.226

Evaluating Ebola therapies--the case for RCTs.

1. The Confounding Question of Confounding Causes in Randomized Trials.

2. Monitoring and Assessment of Medical Countermeasures as Part of a Public Health Emergency Response.

3. A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection.

4. Evaluating Anti-Infective Drugs in the Resistant Pathogen Setting: Can we Use External Controls?

5. Design of a Randomized Controlled Trial for Ebola Virus Disease Medical Countermeasures: PREVAIL II, the Ebola MCM Study.

6. Graphene-VP40 interactions and potential disruption of the Ebola virus matrix filaments.

7. Selecting the right tool for the job.

8. QnAs with Luciana Borio.

9. Comment: Fundamentals and Innovation in Antibiotic Trials.

10. The Past Need Not Be Prologue: Recommendations for Testing and Positioning the Most-Promising Medical Countermeasures for the Next Outbreak of Ebola Virus Infection.